BamSEC and AlphaSense Join Forces
Learn More

Emergent BioSolutions Inc.

NYSE: EBS    
Share price (1/3/25): $10.32    
Market cap (1/3/25): $559 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2
from 8-K 70 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2
from 8-K 116 pages Confidential Treatment Has Been Requested as to Certain Portions of This Document. Each Such Portion, Which Has Been Omitted Herein and Replaced With Asterisks (***), Has Been Filed Separately With the Securities and Exchange Commission. Share Purchase Agreement Among the Sellers Identified Herein, and Emergent Biosolutions Inc. and Seamus Mulligan, as the Sellers’ Representative and Adapt Pharma Limited Dated as of August 28, 2018
12/34/56
EX-2.1
from 8-K 95 pages Confidential Treatment Has Been Requested as to Certain Portions of This Document. Each Such Portion, Which Has Been Omitted Herein and Replaced With Asterisks (***), Has Been Filed Separately With the Securities and Exchange Commission. Agreement and Plan of Merger by and Among Emergent Biosolutions Inc., Panama Merger Sub, Ltd., Paxvax Holding Company Ltd., and Paxvax Sh Representative LLC, as the Shareholder Representative Dated as of August 8, 2018
12/34/56
EX-2
from 8-K 4 pages July 19, 2017 Asset Purchase Agreement
12/34/56
EX-2
from 8-K 5 pages Asset Purchase Agreement Between Sanofi Pasteur Biologics, LLC, Acambis Research Ltd., and Emergent Biosolutions Inc. Dated July 14, 2017
12/34/56
EX-2.2
from 8-K 4 pages Separation and Distribution Agreement by and Between Emergent Biosolutions Inc. and Aptevo Therapeutics Inc. Dated as of July 29, 2016
12/34/56
EX-2
from 8-K ~5 pages Contribution Agreement
12/34/56
EX-2
from 8-K 11 pages Emergent Biosolutions Inc. -And- 2396638 Ontario Inc. -And- Cangene Corporation Arrangement Agreement December 11, 2013
12/34/56
EX-2.1
from 8-K 83 pages Agreement and Plan of Merger by and Among Emergent Biosolutions Inc., 35406 LLC, 30333 Inc. and Trubion Pharmaceuticals, Inc. Dated as of August 12, 2010 Agreement and Plan of Merger and Reorganization
12/34/56
EX-2.1
from 425 83 pages Agreement and Plan of Merger by and Among Emergent Biosolutions Inc., 35406 LLC, 30333 Inc. and Trubion Pharmaceuticals, Inc. Dated as of August 12, 2010 Agreement and Plan of Merger and Reorganization
12/34/56
EX-2
from SC 13G 5 pages Item 2. Identity and Background
12/34/56